Research with human participants

Overview of medical research in the Netherlands

Immune response to pandemische influenza A/H1N1 vaccination in the immunocompromised.

Published:
Last updated:

-

Download: PDF | XML
Ethical review
Approved WMO
Status
Recruitment stopped
Health condition type
Viral infectious disorders
Study type
Observational invasive

ID

NL-OMON32477

Source

ToetsingOnline

Brief title

RICH -3

Condition

  • Viral infectious disorders

Synonym

flu, influenza

Research involving

Human

Sponsors and support

Primary sponsor :
Leids Universitair Medisch Centrum
Source(s) of monetary or material Support :
Er loopt een aanvraag voor externe financiering door een charitatieve instelling

Intervention

Keyword :
A/H1N1, HIV, Influenza

Outcome measures

Primary outcome

-

Secondary outcome

-

Background summary

-

Study objective

-

Study design

-

Study burden and risks

-

Public
Leids Universitair Medisch Centrum

Albinusdreef 2
2333 ZA Leiden
Nederland
Scientific
Leids Universitair Medisch Centrum

Albinusdreef 2
2333 ZA Leiden
Nederland

Listed location countries

Netherlands

Age

Adults (18-64 years)
Elderly (65 years and older)

Inclusion criteria

-

Exclusion criteria

-

Design

Study phase :
4
Study type :
Observational invasive
Intervention model
:
Other
Allocation :
Non-randomized controlled trial
Masking :
Open (masking not used)
Control :
Active
Primary purpose :
Other

Recruitment

NL
Recruitment status
:
Recruitment stopped
Start date (anticipated) :
Enrollment :
195
Type :
Actual

Approved WMO
Date :
Application type :
First submission
Review commission :
METC Leids Universitair Medisch Centrum (Leiden)

Followed up by the following (possibly more current) registration

No registrations found.

Other (possibly less up-to-date) registrations in this register

No registrations found.

In other registers

Register ID
CCMO NL30106.058.09